Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Tumor budding as a useful prognostic marker in T1-stage squamous cell carcinoma of the esophagus.

Teramoto H, Koike M, Tanaka C, Yamada S, Nakayama G, Fujii T, Sugimoto H, Fujiwara M, Suzuki Y, Kodera Y.

J Surg Oncol. 2013 Jul;108(1):42-6. doi: 10.1002/jso.23341. Epub 2013 Apr 22.

2.

Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor.

Koike M, Kodera Y, Itoh Y, Nakayama G, Fujiwara M, Hamajima N, Nakao A.

Ann Surg Oncol. 2008 Jul;15(7):1977-82. doi: 10.1245/s10434-008-9901-6. Epub 2008 Apr 12.

PMID:
18408975
3.

Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.

Chao YK, Chan SC, Liu YH, Chen HW, Wan YL, Chang HK, Fan KH, Liu HP.

Ann Surg. 2009 Mar;249(3):392-6. doi: 10.1097/SLA.0b013e3181949e9f.

PMID:
19247024
4.

Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.

Miyata H, Yoshioka A, Yamasaki M, Nushijima Y, Takiguchi S, Fujiwara Y, Nishida T, Mano M, Mori M, Doki Y.

Cancer. 2009 Jul 15;115(14):3324-34. doi: 10.1002/cncr.24390.

5.

Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor.

Tong DK, Law S, Kwong DL, Chan KW, Lam AK, Wong KH.

Ann Surg Oncol. 2010 Aug;17(8):2184-92. doi: 10.1245/s10434-010-0995-2. Epub 2010 Mar 9.

6.
7.

Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus.

Tachibana M, Kinugasa S, Dhar DK, Kotoh T, Shibakita M, Ohno S, Masunaga R, Kubota H, Kohno H, Nagasue N.

J Surg Oncol. 1999 Oct;72(2):88-93.

PMID:
10518105
8.

Prognostic analysis of the patients with stage-III esophageal squamous cell carcinoma after radical esophagectomy.

Hu Y, Zheng B, Rong TH, Fu JH, Zhu ZH, Yang H, Luo KJ, Li YF.

Chin J Cancer. 2010 Feb;29(2):178-83.

9.

Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.

Dhar DK, Hattori S, Tonomoto Y, Shimoda T, Kato H, Tachibana M, Matsuura K, Mitsumoto Y, Little AG, Nagasue N.

Ann Thorac Surg. 2007 Apr;83(4):1265-72.

PMID:
17383324
10.

Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.

Chen G, Wang Z, Liu XY, Zhang MY, Liu FY.

Eur J Cardiothorac Surg. 2009 Jan;35(1):1-7. doi: 10.1016/j.ejcts.2008.09.002. Epub 2008 Oct 15.

PMID:
18926712
11.

Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection.

Igaki H, Kato H, Tachimori Y, Sato H, Daiko H, Nakanishi Y.

Eur J Cardiothorac Surg. 2001 Jun;19(6):887-93.

PMID:
11404147
12.

Squamous cell carcinoma of the esophagus infiltrating the respiratory tract is less sensitive to preoperative concurrent radiation and chemotherapy.

Yano M, Shiozaki H, Tsujinaka T, Inoue M, Doki Y, Fujiwara Y, Monden M.

J Am Coll Surg. 2000 Dec;191(6):626-34.

PMID:
11129811
13.

Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences.

Gockel I, Kneist W, Junginger T.

World J Surg. 2006 Feb;30(2):183-90.

PMID:
16425075
14.

Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma.

Wang BY, Liu CY, Lin CH, Hsu PK, Hsu WH, Wu YC, Cheng CY.

Ann Surg Oncol. 2012 Jul;19(7):2149-58. doi: 10.1245/s10434-012-2273-y. Epub 2012 Mar 10.

PMID:
22407313
15.

The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.

Brücher BL, Becker K, Lordick F, Fink U, Sarbia M, Stein H, Busch R, Zimmermann F, Molls M, Höfler H, Siewert JR.

Cancer. 2006 May 15;106(10):2119-27.

16.

Prognostic factors after combined modality treatment of squamous cell carcinoma of the esophagus.

Rizk NP, Seshan VE, Bains MS, Ilson DH, Minsky BD, Tang L, Rusch VW.

J Thorac Oncol. 2007 Dec;2(12):1117-23.

17.

[Cox regression analysis of the prognostic factors of unresectable esophageal carcinoma after stenting].

Fu JH, Rong TH, Li XD, Ma GW, Hu Y, Min HQ.

Ai Zheng. 2003 Jan;22(1):91-4. Chinese.

PMID:
12561445
18.

Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.

Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T, Hatakeyama K.

J Am Coll Surg. 2004 Feb;198(2):205-11.

PMID:
14759776
19.

An audit of surgical outcomes of esophageal squamous cell carcinoma.

Goan YG, Chang HC, Hsu HK, Chou YP.

Eur J Cardiothorac Surg. 2007 Mar;31(3):536-44. Epub 2007 Jan 11.

PMID:
17222561
20.

A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.

Sato Y, Motoyama S, Maruyama K, Okuyama M, Ogawa J.

J Am Coll Surg. 2005 Aug;201(2):188-93.

PMID:
16038814

Supplemental Content

Support Center